Daniel W Shaw

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations
    Daniel W Shaw
    Division of Dermatology, University of California, San Diego, CA 92122 1010, USA
    Contact Dermatitis 68:369-75. 2013
  2. ncbi request reprint Dosage considerations in patch testing with liquid allergens
    Daniel W Shaw
    University of California, San Diego, Department of Medicine, San Diego, CA 92103 8420, USA
    Contact Dermatitis 47:86-90. 2002
  3. ncbi request reprint Allergic contact dermatitis from tacrolimus
    Daniel W Shaw
    Department of Medicine, University of California, San Diego, California 92103 8420, USA
    J Am Acad Dermatol 50:962-5. 2004
  4. ncbi request reprint Allergic contact dermatitis from pimecrolimus in a patient with tacrolimus allergy
    Daniel W Shaw
    Department of Medicine, Division of Dermatology, University of California, San Diego 92103 8420, USA
    J Am Acad Dermatol 56:342-5. 2007
  5. ncbi request reprint Allergic contact dermatitis from carmine
    Daniel W Shaw
    Division of Dermatology, University of California, San Diego, San Diego, CA, USA
    Dermatitis 20:292-5. 2009
  6. ncbi request reprint Allergic contact dermatitis from 12-hydroxystearic Acid and hydrogenated castor oil
    Daniel W Shaw
    University of California, San Diego, San Diego, CA, USA
    Dermatitis 20:E16-20. 2009
  7. ncbi request reprint Allergic contact dermatitis from octisalate and cis-3-hexenyl salicylate
    Daniel W Shaw
    Division of Dermatology, Department of Medicine, University of California, San Diego, CA, USA
    Dermatitis 17:152-5. 2006

Detail Information

Publications7

  1. doi request reprint Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations
    Daniel W Shaw
    Division of Dermatology, University of California, San Diego, CA 92122 1010, USA
    Contact Dermatitis 68:369-75. 2013
    ..Tixocortol-21-pivalate (tixocortol pivalate) is used as a surrogate marker for contact allergy to hydrocortisone and other corticosteroids...
  2. ncbi request reprint Dosage considerations in patch testing with liquid allergens
    Daniel W Shaw
    University of California, San Diego, Department of Medicine, San Diego, CA 92103 8420, USA
    Contact Dermatitis 47:86-90. 2002
    ..Selection of dropper bottles should consider drop volume reproducibility, differing drop volumes for different allergens, and the patch test chamber system being used...
  3. ncbi request reprint Allergic contact dermatitis from tacrolimus
    Daniel W Shaw
    Department of Medicine, University of California, San Diego, California 92103 8420, USA
    J Am Acad Dermatol 50:962-5. 2004
    ..This is likely to be caused in part by the high molecular weight of tacrolimus. A similar phenomenon may occur when patch testing with neomycin sulfate...
  4. ncbi request reprint Allergic contact dermatitis from pimecrolimus in a patient with tacrolimus allergy
    Daniel W Shaw
    Department of Medicine, Division of Dermatology, University of California, San Diego 92103 8420, USA
    J Am Acad Dermatol 56:342-5. 2007
    ..Higher concentrations of pimecrolimus were not available for testing. Patch tests on 30 control patients with pimecrolimus cream 1% were negative...
  5. ncbi request reprint Allergic contact dermatitis from carmine
    Daniel W Shaw
    Division of Dermatology, University of California, San Diego, San Diego, CA, USA
    Dermatitis 20:292-5. 2009
    ..These are immunoglobulin E-mediated reactions directed against cochineal proteins...
  6. ncbi request reprint Allergic contact dermatitis from 12-hydroxystearic Acid and hydrogenated castor oil
    Daniel W Shaw
    University of California, San Diego, San Diego, CA, USA
    Dermatitis 20:E16-20. 2009
    ..In addition, serial dilution testing demonstrated that saturation of the hydroxylated C18 fatty acid enhanced its allergenicity...
  7. ncbi request reprint Allergic contact dermatitis from octisalate and cis-3-hexenyl salicylate
    Daniel W Shaw
    Division of Dermatology, Department of Medicine, University of California, San Diego, CA, USA
    Dermatitis 17:152-5. 2006
    ..Results of patch testing and provocative use testing confirmed that she was allergic to octisalate. Provocative use testing indicated that she was also allergic to cis-3-hexenyl salicylate...